Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report

Rheumatology (Oxford). 2021 Feb 1;60(2):e39-e40. doi: 10.1093/rheumatology/keaa389.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Female
  • Humans
  • Immunity, Cellular / drug effects*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • pembrolizumab